Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Suma Ramadas, PhD
Medical Affairs

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Stacey Gandler
Brand Nourishment